Arvinas (ARVN) Net Margin Growth (3y) (2020 - 2026)
Powered by 
Analysis
Arvinas (ARVN) Net Margin Growth (3y) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn | -374.00 |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn | -44.00 |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | 6,620.00 |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | -13,815.00 |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn | 7,793.00 |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | 9,934.00 |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - | -5,319.00 |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 31,387.00 |
| 10 | Arvinas | 605.88 Mn | 37.98 Mn | - | 18,766.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18,766.00 |
| Mar 31, 2026 | -12,062.00 |
| Dec 31, 2025 | -49,757.00 |
| Sep 30, 2025 | 10,689.00 |
| Jun 30, 2025 | -7,351.00 |
| Mar 31, 2025 | 27,447.00 |
| Dec 31, 2024 | 6,267.00 |
| Sep 30, 2024 | 45,518.00 |
| Jun 30, 2024 | 86,853.00 |
| Mar 31, 2024 | 47,115.00 |
| Dec 31, 2023 | 97,305.00 |
| Sep 30, 2023 | 22,291.00 |
| Jun 30, 2023 | 32,444.00 |
| Mar 31, 2023 | 10,604.00 |
| Dec 31, 2022 | 21,823.00 |
| Sep 30, 2022 | -13,184.00 |
| Jun 30, 2022 | 22,765.00 |
| Mar 31, 2022 | 12,807.00 |
| Dec 31, 2021 | 32,879.00 |
| Sep 30, 2021 | 321,317.00 |